Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.23
+0.09 (1.75%)
At close: Aug 5, 2026, 4:00 PM EDT
5.25
+0.02 (0.38%)
After-hours: Aug 5, 2026, 4:10 PM EDT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $488.51 million as of August 5, 2026. Its market cap has decreased by -22.78% in one year.
Market Cap
488.51M
Enterprise Value
608.87M
1-Year Change
-22.78%
Ranking
Category
Stock Price
$5.23
ChartMarket Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $488.51M, a decrease of -62.21%. That is a compound annual growth rate of -16.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 488.51M | -35.22% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verastem | 515.82M |
| Assembly Biosciences | 514.00M |
| Rezolute | 513.98M |
| Autolus Therapeutics | 505.67M |
| Ovid Therapeutics | 495.53M |
| ProKidney | 493.87M |
| Evommune | 479.40M |
| Q32 Bio | 478.31M |